Critical role of IRF-5 in regulation of B-cell differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 10, 2010, Pages 4664-4668

  Lien, Chunyang ^a   Fang, Chee Mun ^b   Huso, David ^c   Livak, Ferenc ^d   Lu, Runqing ^e   Pitha, Paula M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antigenic response; B cell development; Blimp 1; IRF 5; Toll like receptors

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 6; RNA; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FLOW CYTOMETRY; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SPLENOMEGALY; STRAIN DIFFERENCE; VIRUS INFECTION;

AGE FACTORS; ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMA CELLS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; SPLENOMEGALY; TRANSCRIPTION FACTORS;

MUS;

EID: 77949518633     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911193107     Document Type: Article

References (42)

1. Paun A, Pitha PM (2007) The IRF family, revisited. Biochimie 89:744-753.
2. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623-655.
3. Takaoka A, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249.
4. Paun A, et al. (2008) Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J Biol Chem 283: 14295-14308.
5. Mancl ME, et al. (2005) Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 280: 21078-21090.
6. Graham RR, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 104: 6758-6763.
7. Sigurdsson S, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76:528-537.
8. Baumgarth N, et al. (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192:271-280.
9. Savitsky D, Calame K (2006) B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J Exp Med 203:2305-2314.
10. Fuxa M, Skok JA (2007) Transcriptional regulation in early B cell development. Curr Opin Immunol 19:129-136.
11. Delogu A, et al. (2006) Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24:269-281.
12. Kallies A, et al. (2007) Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1. Immunity 26:555-566.
13. Shaffer AL, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51-62.
14. Martins GA, Cimmino L, Liao J, Magnusdottir E, Calame K (2008) Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J Exp Med 205:1959-1965.
15. Schliephake DE, Schimpl A (1996) Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab?)2-co-stimulated B lymphocytes. Eur J Immunol 26: 268-271.
16. Sciammas R, et al. (2006) Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25:225-236.
17. Tunyaplin C, Shapiro MA, Calame KL (2000) Characterization of the B lymphocyteinduced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter. Nucleic Acids Res 28:4846-4855.
18. Lu R, Medina KL, Lancki DW, Singh H (2003) IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev 17:1703-1708.
19. Wang H, et al. (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112:4028-4038.
20. Saito M, et al. (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12:280-292.
21. Klein U, et al. (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7:773-782.
22. Pathak S, Ma S, Trinh L, Lu R (2008) A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol 28:2815-2824.
23. Lee CH, et al. (2006) Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med 203: 63-72.
24. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364-368.
25. Guay HM, Andreyeva TA, Garcea RL, Welsh RM, Szomolanyi-Tsuda E (2007) MyD88 is required for the formation of long-term humoral immunity to virus infection. J Immunol 178:5124-5131.
26. Barr TA, Brown S, Mastroeni P, Gray D (2009) B cell intrinsic MyD88 signals drive IFNgamma production from T cells and control switching to IgG2c. J Immunol 183: 1005-1012.
27. Turner CA, Jr, Mack DH, Davis MM (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulinsecreting cells. Cell 77:297-306.
28. Lin KI, Lin Y, Calame K (2000) Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol Cell Biol 20:8684-8695.
29. Klein U, Dalla-Favera R (2008) Germinal centres: Role in B-cell physiology and malignancy. Nat Rev Immunol 8:22-33.
30. Blink EJ, et al. (2005) Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 201:545-554.
31. Johnston RJ, et al. (2009) Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325:1006-1010.
32. Negishi H, et al. (2005) Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci USA 102:15989-15994.
33. Coro ES, Chang WL, Baumgarth N (2006) Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 176:4343-4351.
34. Kuo TC, Calame KL (2004) B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J Immunol 173:5556-5563.
35. Keller AD, Maniatis T (1991) Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 5:868-879.
36. Tunyaplin C, et al. (2004) Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 173:1158-1165.
37. Phan RT, Dalla-Favera R (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432:635-639.
38. Lenz G, et al. (2007) Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 204: 633-643.
39. Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 63:6424-6431.
40. Yang L, et al. (2009) Functional analysis of a dominant negative mutation of interferon regulatory factor 5. PLoS One 4:e5500.
41. Wies E, et al. (2009) The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J Biol Chem 284:8525-8538.
42. Ma S, Turetsky A, Trinh L, Lu R (2006) IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J Immunol 177:7898-7904.